Relationship between glucosamine use and the risk of lung cancer: data from a nationwide prospective cohort study

Relationship between glucosamine use and the risk of lung cancer: data from a nationwide prospective cohort study

Research on glucosamine shows anti-inflammatory and anti-cancer benefits with minimal adverse effects. We aimed to explore the relationship between use of glucosamine and risk of lung cancer and lung cancer mortality based on data from the large-scale nationwide prospective UK Biobank cohort study....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The European respiratory journal 2022-03, Vol.59 (3), p.2101399
Hauptverfasser: Li, Guowei, Zhang, Xuhui, Liu, Yingxin, Zhang, Junguo, Li, Likang, Huang, Xin, Thabane, Lehana, Lip, Gregory Y H
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 3
container_start_page 2101399
container_title The European respiratory journal
container_volume 59
creator Li, Guowei
Zhang, Xuhui
Liu, Yingxin
Zhang, Junguo
Li, Likang
Huang, Xin
Thabane, Lehana
Lip, Gregory Y H
description Research on glucosamine shows anti-inflammatory and anti-cancer benefits with minimal adverse effects. We aimed to explore the relationship between use of glucosamine and risk of lung cancer and lung cancer mortality based on data from the large-scale nationwide prospective UK Biobank cohort study. Participants were enrolled between 2006 and 2010 and followed-up to 2020. The Cox proportional hazards model was used to assess the relationship between glucosamine use and risk of lung cancer and lung cancer mortality. Subgroup analyses and sensitivity analyses were performed to explore the potential effect modifications and the robustness of the main findings. 439 393 participants (mean age 56 years; 53% females) with a mean follow-up of 11 years were included for analyses. 82 603 (18.80%) participants reported regular use of glucosamine at baseline. During follow-up, 1971 (0.45%) lung cancer events were documented. Glucosamine use was significantly associated with a decreased risk of lung cancer (hazard ratio (HR) 0.84, 95% CI 0.75-0.92; p
doi_str_mv 10.1183/13993003.01399-2021
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2557222087</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2557222087</sourcerecordid><originalsourceid>FETCH-LOGICAL-c350t-129632b0410998c662ed8edb549c07e1bb2025df42eefb5d625125704b74a03e3</originalsourceid><addsrcrecordid>eNo9kElPwzAQhS0EoqXwC5CQj1xSxnY2c0MVm1QJCcE5cuxJa8jW2KHqvycpLad5Gr03y0fINYM5Y6m4Y0JKASDmMKqAA2cnZLrXY_uUTEGCCJgU8YRcOPcFwOJQsHMyEaHgMUvllGzesVTeNrVb25bm6LeINV2VvW6cqmyNtHdIVW2oXyPtrPumTUHLvl5RrWqN3T01yitadE1FFa33s7bWIG27xrWovf1Bqpt103nqfG92l-SsUKXDq0Odkc-nx4_FS7B8e35dPCwDLSLwAeMyFjyHkIGUqY5jjiZFk0eh1JAgy_Ph4cgUIUcs8sjEPGI8SiDMk1CBQDEjt39zh0M2PTqfVdZpLEtVY9O7jEdRwjmHNBms4s-qh5tdh0XWdrZS3S5jkI2ssyPrbM86G1kPqZvDgj6v0PxnjnDFL-Foel0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2557222087</pqid></control><display><type>article</type><title>Relationship between glucosamine use and the risk of lung cancer: data from a nationwide prospective cohort study</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Li, Guowei ; Zhang, Xuhui ; Liu, Yingxin ; Zhang, Junguo ; Li, Likang ; Huang, Xin ; Thabane, Lehana ; Lip, Gregory Y H</creator><creatorcontrib>Li, Guowei ; Zhang, Xuhui ; Liu, Yingxin ; Zhang, Junguo ; Li, Likang ; Huang, Xin ; Thabane, Lehana ; Lip, Gregory Y H</creatorcontrib><description>Research on glucosamine shows anti-inflammatory and anti-cancer benefits with minimal adverse effects. We aimed to explore the relationship between use of glucosamine and risk of lung cancer and lung cancer mortality based on data from the large-scale nationwide prospective UK Biobank cohort study. Participants were enrolled between 2006 and 2010 and followed-up to 2020. The Cox proportional hazards model was used to assess the relationship between glucosamine use and risk of lung cancer and lung cancer mortality. Subgroup analyses and sensitivity analyses were performed to explore the potential effect modifications and the robustness of the main findings. 439 393 participants (mean age 56 years; 53% females) with a mean follow-up of 11 years were included for analyses. 82 603 (18.80%) participants reported regular use of glucosamine at baseline. During follow-up, 1971 (0.45%) lung cancer events were documented. Glucosamine use was significantly associated with a decreased risk of lung cancer (hazard ratio (HR) 0.84, 95% CI 0.75-0.92; p&lt;0.001) and lung cancer mortality (HR 0.88, 95% CI 0.81-0.96; p=0.002) in fully adjusted models. A stronger association between glucosamine use and decreased lung cancer risk was observed in participants with a family history of lung cancer when compared with those without a family history. Regular use of glucosamine was significantly related with decreased risk of lung cancer and lung cancer mortality, based on data from this nationwide prospective cohort study.</description><identifier>ISSN: 0903-1936</identifier><identifier>EISSN: 1399-3003</identifier><identifier>DOI: 10.1183/13993003.01399-2021</identifier><identifier>PMID: 34326189</identifier><language>eng</language><publisher>England</publisher><ispartof>The European respiratory journal, 2022-03, Vol.59 (3), p.2101399</ispartof><rights>Copyright ©The authors 2022. For reproduction rights and permissions contact permissions@ersnet.org.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c350t-129632b0410998c662ed8edb549c07e1bb2025df42eefb5d625125704b74a03e3</citedby><cites>FETCH-LOGICAL-c350t-129632b0410998c662ed8edb549c07e1bb2025df42eefb5d625125704b74a03e3</cites><orcidid>0000-0003-3069-9484</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34326189$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Guowei</creatorcontrib><creatorcontrib>Zhang, Xuhui</creatorcontrib><creatorcontrib>Liu, Yingxin</creatorcontrib><creatorcontrib>Zhang, Junguo</creatorcontrib><creatorcontrib>Li, Likang</creatorcontrib><creatorcontrib>Huang, Xin</creatorcontrib><creatorcontrib>Thabane, Lehana</creatorcontrib><creatorcontrib>Lip, Gregory Y H</creatorcontrib><title>Relationship between glucosamine use and the risk of lung cancer: data from a nationwide prospective cohort study</title><title>The European respiratory journal</title><addtitle>Eur Respir J</addtitle><description>Research on glucosamine shows anti-inflammatory and anti-cancer benefits with minimal adverse effects. We aimed to explore the relationship between use of glucosamine and risk of lung cancer and lung cancer mortality based on data from the large-scale nationwide prospective UK Biobank cohort study. Participants were enrolled between 2006 and 2010 and followed-up to 2020. The Cox proportional hazards model was used to assess the relationship between glucosamine use and risk of lung cancer and lung cancer mortality. Subgroup analyses and sensitivity analyses were performed to explore the potential effect modifications and the robustness of the main findings. 439 393 participants (mean age 56 years; 53% females) with a mean follow-up of 11 years were included for analyses. 82 603 (18.80%) participants reported regular use of glucosamine at baseline. During follow-up, 1971 (0.45%) lung cancer events were documented. Glucosamine use was significantly associated with a decreased risk of lung cancer (hazard ratio (HR) 0.84, 95% CI 0.75-0.92; p&lt;0.001) and lung cancer mortality (HR 0.88, 95% CI 0.81-0.96; p=0.002) in fully adjusted models. A stronger association between glucosamine use and decreased lung cancer risk was observed in participants with a family history of lung cancer when compared with those without a family history. Regular use of glucosamine was significantly related with decreased risk of lung cancer and lung cancer mortality, based on data from this nationwide prospective cohort study.</description><issn>0903-1936</issn><issn>1399-3003</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNo9kElPwzAQhS0EoqXwC5CQj1xSxnY2c0MVm1QJCcE5cuxJa8jW2KHqvycpLad5Gr03y0fINYM5Y6m4Y0JKASDmMKqAA2cnZLrXY_uUTEGCCJgU8YRcOPcFwOJQsHMyEaHgMUvllGzesVTeNrVb25bm6LeINV2VvW6cqmyNtHdIVW2oXyPtrPumTUHLvl5RrWqN3T01yitadE1FFa33s7bWIG27xrWovf1Bqpt103nqfG92l-SsUKXDq0Odkc-nx4_FS7B8e35dPCwDLSLwAeMyFjyHkIGUqY5jjiZFk0eh1JAgy_Ph4cgUIUcs8sjEPGI8SiDMk1CBQDEjt39zh0M2PTqfVdZpLEtVY9O7jEdRwjmHNBms4s-qh5tdh0XWdrZS3S5jkI2ssyPrbM86G1kPqZvDgj6v0PxnjnDFL-Foel0</recordid><startdate>202203</startdate><enddate>202203</enddate><creator>Li, Guowei</creator><creator>Zhang, Xuhui</creator><creator>Liu, Yingxin</creator><creator>Zhang, Junguo</creator><creator>Li, Likang</creator><creator>Huang, Xin</creator><creator>Thabane, Lehana</creator><creator>Lip, Gregory Y H</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3069-9484</orcidid></search><sort><creationdate>202203</creationdate><title>Relationship between glucosamine use and the risk of lung cancer: data from a nationwide prospective cohort study</title><author>Li, Guowei ; Zhang, Xuhui ; Liu, Yingxin ; Zhang, Junguo ; Li, Likang ; Huang, Xin ; Thabane, Lehana ; Lip, Gregory Y H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c350t-129632b0410998c662ed8edb549c07e1bb2025df42eefb5d625125704b74a03e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Guowei</creatorcontrib><creatorcontrib>Zhang, Xuhui</creatorcontrib><creatorcontrib>Liu, Yingxin</creatorcontrib><creatorcontrib>Zhang, Junguo</creatorcontrib><creatorcontrib>Li, Likang</creatorcontrib><creatorcontrib>Huang, Xin</creatorcontrib><creatorcontrib>Thabane, Lehana</creatorcontrib><creatorcontrib>Lip, Gregory Y H</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The European respiratory journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Guowei</au><au>Zhang, Xuhui</au><au>Liu, Yingxin</au><au>Zhang, Junguo</au><au>Li, Likang</au><au>Huang, Xin</au><au>Thabane, Lehana</au><au>Lip, Gregory Y H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Relationship between glucosamine use and the risk of lung cancer: data from a nationwide prospective cohort study</atitle><jtitle>The European respiratory journal</jtitle><addtitle>Eur Respir J</addtitle><date>2022-03</date><risdate>2022</risdate><volume>59</volume><issue>3</issue><spage>2101399</spage><pages>2101399-</pages><issn>0903-1936</issn><eissn>1399-3003</eissn><abstract>Research on glucosamine shows anti-inflammatory and anti-cancer benefits with minimal adverse effects. We aimed to explore the relationship between use of glucosamine and risk of lung cancer and lung cancer mortality based on data from the large-scale nationwide prospective UK Biobank cohort study. Participants were enrolled between 2006 and 2010 and followed-up to 2020. The Cox proportional hazards model was used to assess the relationship between glucosamine use and risk of lung cancer and lung cancer mortality. Subgroup analyses and sensitivity analyses were performed to explore the potential effect modifications and the robustness of the main findings. 439 393 participants (mean age 56 years; 53% females) with a mean follow-up of 11 years were included for analyses. 82 603 (18.80%) participants reported regular use of glucosamine at baseline. During follow-up, 1971 (0.45%) lung cancer events were documented. Glucosamine use was significantly associated with a decreased risk of lung cancer (hazard ratio (HR) 0.84, 95% CI 0.75-0.92; p&lt;0.001) and lung cancer mortality (HR 0.88, 95% CI 0.81-0.96; p=0.002) in fully adjusted models. A stronger association between glucosamine use and decreased lung cancer risk was observed in participants with a family history of lung cancer when compared with those without a family history. Regular use of glucosamine was significantly related with decreased risk of lung cancer and lung cancer mortality, based on data from this nationwide prospective cohort study.</abstract><cop>England</cop><pmid>34326189</pmid><doi>10.1183/13993003.01399-2021</doi><orcidid>https://orcid.org/0000-0003-3069-9484</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0903-1936
ispartof The European respiratory journal, 2022-03, Vol.59 (3), p.2101399
issn 0903-1936
1399-3003
language eng
recordid cdi_proquest_miscellaneous_2557222087
source EZB-FREE-00999 freely available EZB journals
title Relationship between glucosamine use and the risk of lung cancer: data from a nationwide prospective cohort study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T00%3A48%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Relationship%20between%20glucosamine%20use%20and%20the%20risk%20of%20lung%20cancer:%20data%20from%20a%20nationwide%20prospective%20cohort%20study&rft.jtitle=The%20European%20respiratory%20journal&rft.au=Li,%20Guowei&rft.date=2022-03&rft.volume=59&rft.issue=3&rft.spage=2101399&rft.pages=2101399-&rft.issn=0903-1936&rft.eissn=1399-3003&rft_id=info:doi/10.1183/13993003.01399-2021&rft_dat=%3Cproquest_cross%3E2557222087%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2557222087&rft_id=info:pmid/34326189&rfr_iscdi=true